Vitalhub (TSE:VHI - Get Free Report) had its price target decreased by research analysts at ATB Cormark Capital Markets from C$16.50 to C$15.00 in a research report issued on Tuesday,BayStreet.CA reports. The brokerage currently has an "outperform" rating on the stock. ATB Cormark Capital Markets' price target would suggest a potential upside of 80.72% from the company's current price.
Other research analysts also recently issued research reports about the stock. Scotiabank lowered their price target on shares of Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating for the company in a report on Wednesday, February 4th. Royal Bank Of Canada reduced their price target on shares of Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating on the stock in a research note on Monday, January 26th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. Based on data from MarketBeat, Vitalhub currently has an average rating of "Buy" and an average target price of C$14.43.
Get Our Latest Stock Analysis on VHI
Vitalhub Stock Performance
Shares of Vitalhub stock traded down C$0.12 during trading hours on Tuesday, hitting C$8.30. The company's stock had a trading volume of 117,538 shares, compared to its average volume of 358,087. The business has a 50 day moving average price of C$8.52 and a two-hundred day moving average price of C$9.77. Vitalhub has a 12-month low of C$7.63 and a 12-month high of C$14.64. The company has a market cap of C$523.90 million, a PE ratio of 207.50, a PEG ratio of 1.18 and a beta of 0.65.
Insider Buying and Selling at Vitalhub
In related news, Director Anthony Pius Shen purchased 5,470 shares of the business's stock in a transaction on Tuesday, December 23rd. The shares were bought at an average cost of C$9.23 per share, with a total value of C$50,488.10. Following the transaction, the director owned 5,470 shares of the company's stock, valued at approximately C$50,488.10. This trade represents a ∞ increase in their ownership of the stock. Also, Director Francis Nelson Shen acquired 148,700 shares of Vitalhub stock in a transaction on Tuesday, December 23rd. The shares were bought at an average price of C$9.05 per share, with a total value of C$1,345,735.00. Following the purchase, the director directly owned 148,700 shares in the company, valued at approximately C$1,345,735. The trade was a ∞ increase in their position. Company insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.